ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 782

Temporal Artery Microbiome in Giant Cell Arteritis

Alison Clifford*1, Pauline Funchain*2,3,4, Lisa Lystad5, Charissa Peterson4, Jessica Altemus4, Gary S. Hoffman1 and Charis Eng2,3,4,6, 1Center for Vasculitis Care and Research, Cleveland Clinic Foundation, Cleveland, OH, 2Taussig Cancer Institute, Cleveland Clinic Foundation, Cleveland, OH, 3Case Comprehensive Cancer Center, Case Western Reserve University School of Medicine, Cleveland, OH, 4Genomic Medicine Institute, Lerner Research Institute, Cleveland, OH, 5Cole Eye Institute, Cleveland Clinic Foundation, Cleveland, OH, 6Department of Genetics and Genome Sciences, Case Western Reserve University School of Medicine, Cleveland, OH

Meeting: 2014 ACR/ARHP Annual Meeting

Keywords: genomics, giant cell arteritis, microbiome and temporal arteritis

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Title: Vasculitis

Session Type: Abstract Submissions (ACR)

Background/Purpose: Whether infectious agents play a part in giant cell arteritis (GCA) remains controversial.  We have performed the first microbiome study of snap-frozen temporal arteries, collected and processed under sterile conditions, from GCA patients and controls using metagenomic sequencing. 

Methods: Patients undergoing temporal artery biopsy for possible GCA were prospectively enrolled.  Biopsies were collected under strictly sterile conditions and split, with one part sent for routine histopathological review and one part snap-frozen for microbiome studies.  Patients were classified according to clinical presentation as either biopsy-positive GCA (TA+), biopsy-negative clinically classical GCA (TA-) or controls.  Long-read 16S ribosomal RNA (rRNA) sequencing was used to describe the entire microbiome of temporal arteries.  Total DNA was isolated, and V1-V4 regions of the gene encoding bacteria-specific 16S rRNA were amplified and Sanger sequenced. Taxonomic classification of bacterial sequences was performed using an in-house analysis pipeline and relative abundances of species were calculated.  Microbiomes were plotted by principal-coordinate analysis (PCoA) using a de novo operational taxonomic unit (OTU) picking protocol (using the MacQIIME 1.7 toolkit).  Functional composition of microbiomes was analyzed using the PICRUSt bioinformatics package.

Results:  Eleven patients were enrolled, including 3 TA+ GCA patients, 2 TA- GCA patients and 6 controls. All patients were receiving empiric prednisone therapy at time of biopsy and 1 control patient was also receiving doxycycline.  Using PCoA, the microbiomes of control temporal arteries clustered tightly together in the center of the plot, showing high degrees of taxonomic relatedness, while GCA microbiomes (both TA+ and TA – patients) plotted in the periphery, clearly separated from controls.  One control outlier was noted.  Stratification of the samples by prednisone dosage did not account for the separation of GCA and controls on PCoA.  Taxonomic classification revealed a wide variety of bacteria in each temporal artery (mean 10.8 species/control vs 10.6 species/GCA), with no overarching species common to all. Significant upregulation of 4 functional pathways (nucleotide metabolism, steroid hormone biosynthesis, biosynthesis of siderophore group nonribosomal peptides, and electron transport) was identified in the GCA microbiomes (both TA+ and TA-) as compared to controls.

Conclusion: Temporal arteries are not sterile.  They are inhabited in both the control and diseased state by a community of bacteria.  GCA temporal artery microbiomes (from both TA+ and TA- patients) differ from controls with respect to both the taxonomy and function of bacterial species present.  Whether these shifts in the GCA microbiome represent the cause or effect of vascular inflammation remains to be elucidated.

* contributed equally to this work


Disclosure:

A. Clifford*,
None;

P. Funchain*,
None;

L. Lystad,
None;

C. Peterson,
None;

J. Altemus,
None;

G. S. Hoffman,
None;

C. Eng,
None.

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2014 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/temporal-artery-microbiome-in-giant-cell-arteritis/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology